Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2

Gut

Volumn 58, Issue 9, 2009, Pages 1250-1259

  Modica, S ^a,b   Morgano, A ^c   Salvatore, L ^a,b   Petruzzelli, M ^a,b   Vanier, M T ^d   Valanzano, R ^e   Esposito, D L ^c   Palasciano, G ^a,b   Duluc, I ^d   Freund, J N ^d   Mariani Costantini, R ^c   Moschetta, A ^a,b  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d INSERM   (France)

^e UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INSULIN RECEPTOR SUBSTRATE 2; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR CDX2;

ADENOMATOUS POLYP; ADENOVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CHROMATIN IMMUNOPRECIPITATION; COLON MUCOSA; COLON POLYPOSIS; COLORECTAL TUMOR; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; INTESTINE CELL; INTESTINE VILLUS; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HT29 CELLS; HUMANS; ILEUM; IMMUNOHISTOCHEMISTRY; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; MALE; MICE; MULTIPLE ENDOCRINE NEOPLASIA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 68849100416     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.158386     Document Type: Article

References (52)

1. Booth C, Potten CS. Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 2000;105:1493-9.
2. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
3. Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998;280:596-9.
4. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
5. Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004;18:1385-90.
6. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
7. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
9. da Costa LT, He TC, Yu J, et al. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene 1999;18:5010-4.
10. Dang DT, Mahatan CS, Dang LH, et al. Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 2001;20:4884- 90.
11. Chawengsaksophak K, James R, Hammond VE, et al. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997;386:84-7.
12. Silberg DG, Swain GP, Suh ER, et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000;119:961-71.
13. Beck F, Chawengsaksophak K, Waring P, et al. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999;96:7318-23.
14. Suh E, Chen L, Taylor J, et al. A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol 1994;14:7340-51.
15. Bai YQ, Miyake S, Iwai T, et al. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene 2003;22:7942-9.
16. Ee HC, Erler T, Bhathal PS, et al. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995;147:586-92.
17. Subtil C, Guerin E, Schneider A, et al. Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability. Cancer Lett 2007;247:197-203.
18. Brabletz T, Spaderna S, Kolb J, et al. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression. Cancer Res 2004;64:6973-7.
19. Aoki K, Tamai Y, Horiike S, et al. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice. Nat Genet 2003;35:323-30.
20. Bonhomme C, Duluc I, Martin E, et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 2003;52:1465-71.
21. Gross I, Duluc I, Benameur T, et al. The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene 2008;27:107-15.
22. Witek ME, Nielsen K, Walters R, et al. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas. Clin Cancer Res 2005;11:8549-56.
23. Martin ES, Tonon G, Sinha R, et al. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 2007;67:10736-43.
24. Dang LH, Chen F, Ying C, et al. CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48. Oncogene 2006;25:2264-72.
25. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006;7:85-96.
26. Burks DJ, Font dM, Schubert M, et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000;407:377-82.
27. Lin X, Taguchi A, Park S, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004;114:908-16.
28. Kubota N, Terauchi Y, Tobe K, et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 2004;114:917-27.
29. Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998;391:900-4.
30. Ramocki NM, Wilkins HR, Magness ST, et al. IRS-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. Endocrinology 2008;149:261-7.
31. Shi B, Sepp-Lorenzino L, Prisco M, et al. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007;282:32582-90.
32. Slattery ML, Samowitz W, Curtin K, et al. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1206-14.
33. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13.
34. Cama A, Palmirotta R, Curia MC, et al. Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations. Hum Mutat 1995;5:144-52.
35. Van de Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-50.
36. Moschetta A, Bookout AL, Mangelsdorf DJ. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004;10:1352-8.
37. Scholl C, Bansal D, Dohner K, et al. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest 2007;117:1037-48.
38. Thomas MA, Lichtenstein DL, Krajcsi P, et al. A real-time PCR method to rapidly titer adenovirus stocks. Methods Mol Med 2007;130:185-92.
39. Iwamoto K, Mori H, Okazawa H, et al. Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene. Diabetologia 2002;45:1182-95.
40. Qualtrough D, Hinoi T, Fearon E, et al. Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut 2002;51:184-90.
41. de Gottardi A, Touri F, Maurer CA, et al. The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer. Dig Dis Sci 2004;49:982-9.
42. Domon-Dell C, Wang Q, Kim S, et al. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells. Gut 2002;50:525-9.
43. Perrini S, Natalicchio A, Laviola L, et al. Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis. Endocrinology 2008;149:1302-13.
44. Su LK, Johnson KA, Smith KJ, et al. Association between wild type and mutant APC gene products. Cancer Res 1993;53:2728- 31.
45. Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 1996;93:7950-4.
46. Traber PG, Wu GD, Wang W. Novel DNA-binding proteins regulate intestine-specific transcription of the sucrase-isomaltase gene. Mol Cell Biol 1992;12:3614-27.
47. White MF. Insulin signaling in health and disease. Science 2003;302:1710-1.
48. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
49. Singh P, Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology 1993;105:1218-37.
50. Werner H, Le Roith D. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit Rev Oncog 1997;8:71-92.
51. Chen J, Wu A, Sun H, et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J Biol Chem 2005;280:29912- 20.
52. Simmons JG, Ling Y, Wilkins H, et al. Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth. Am J Physiol Gastrointest Liver Physiol 2007;293:G995- 1003.